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Background: Cytoplasmic injection of exogenous DNA into zygotes is a promising technique to generate transgenic
livestock. However, it is still relatively inefficient and has not yet been demonstrated to work in buffalo. We sought to
improve two key technical parameters of the procedure, namely i) how much linear DNA to inject and ii) when to
inject it. For this, we introduced a constitutively expressed enhanced green fluorescent protein (EGFP) plasmid into
buffalo zygotes.
Results: First, we found that the proportion of EGFP-expressing blastocysts derived from zygotes injected with 20 or
50 ng/μL DNA was significantly higher than from those injected with 5 μg/mL. However, 50 ng/μL exogenous DNA
compromised blastocyst development compared to non-injected IVF controls. Therefore the highest net yield
of EGFP-positive blastocysts was achieved at 20 ng/μL DNA. Second, zygotes injected early (7–8 h post-insemination
[hpi]) developed better than those injected at mid (12–13 hpi) or late (18–19 hpi) time points. Blastocysts derived from
early injections were also more frequently EGFP-positive. As a consequence, the net yield of EGFP-expressing
blastocysts was more than doubled using early vs late injections (16.4 % vs 7.7 %). With respect to blastocyst quality,
we found no significant difference in cell numbers of EGFP-positive blastocysts vs non-injected blastocysts. Following
embryo transfer of six EGFP-positive blastocysts into four recipient animals, two viable buffalo calves were born.
Biopsied ear tissues from both buffalo calves were analyzed for transgene presence and expression by Southern blot,
PCR and confocal laser scanning microscopy, respectively. This confirmed that both calves were transgenic.
Conclusions: Our cytoplasmic injection protocol improved generation of transgenic embryos and resulted in the first
transgenic buffalo calves produced by this method.
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Livestock transgenesis is a tool for elucidating gene
function and can also play a key role in many biotechno-
logical applications, such as establishing genetic disease
models and producing new animal products [1]. In the
past, transgenic farm animals have been generated by
pronuclear microinjection (reviewed in [2]), somatic nu-
clear transfer cloning (SCNT) and lentiviral infection
(reviewed in [3]). Gene transfer by pronuclear* Correspondence: bjorn.oback@agresearch.co.nz; ardsshi@gxu.edu.cn
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transgenic livestock with 100 % germline transmission
[4, 5]. It has been reported that transgene expression in
bovine and porcine embryos is only approximately 3 %
and 20 %, respectively, with the majority of embryos be-
ing mosaics [6, 7]. Overall, only about 1 % of livestock
embryos from pronuclear injection develop into trans-
genic founders, posing a major obstacle in transgenic
animal production. Likewise, SCNT only results in about
1–5 % of transgenic embryos developing into fertile live
offspring, mainly owing to genetic and epigenetic abnor-
malities associated with the cloning procedure [8]. Lenti-
viral infection of early embryos has increased the
efficiency of transgenesis to 10–30 % [9]. However, these
vectors have other drawbacks, including i) restrictedis distributed under the terms of the Creative Commons Attribution 4.0
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ation of mosaic animals, in which only some cells carry
the transgene [10].
Cytoplasmic DNA injection has emerged as an alterna-
tive method to introduce foreign genes into zygotes. Com-
pared to traditional pronuclear injection, this technique
does not require visualization of the male and female pro-
nuclei. This is an advantage for zygotes whose high lipid
contents disguise the pronuclei, such as in cattle, sheep
and pig [11]. In these species, zygotes are centrifuged
to visualize the pronuclei, an approach which may
compromise their developmental capacity [5]. Using
cytoplasmic injection, transgenic mice [12–15], rats [16],
cynomolgus monkey [17], cattle [18] and pigs [9–21] have
been produced. Using condensed DNA in combination
with electroporation, 2.4 % of injected mouse zygotes devel-
oped into transgene-expressing blastocysts [13]. In order to
further increase efficiency, high concentrations (625 ng/μL)
of divalent cation-complexed DNA was injected, resulting
in a net yield of up to 7.4 % of EGFP-positive murine
morulae/blastocysts [13]. In cattle, injection of naked
DNA into IVF zygotes did first not yield EGFP-
positive blastocysts, however, by injecting DNA–lipo-
some complexes the rate increased to 12 % [22].
In the present study, we introduced linear DNA into
buffalo zygotes by cytoplasmic injection. By varying the
amount of exogenous DNA and time point of injection,
we achieved a doubling in the net production of transgene-
expressing blastocysts. Following blastocyst transfer into
surrogate recipients, we obtained viable transgenic buffalo
calves. Taken together, we established a robust technique
that resulted in the first transgenic buffalo using an opti-
mized cytoplasmic injection protocol.
Methods
Reagents and media
Chemicals were purchased from Sigma-Aldrich (St. Louis,
MO, USA) and all embryo manipulations were carried out
on a warm stage (38.5 °C), unless indicated otherwise.
DNA preparation
The transgenic cassette, a 4.7 kb pEGFP-N1 plasmid
encoding the EGFP gene driven by the CMV promoter
(GenBank Accession #U55762, Clontech, USA), was
purified by using an endotoxin-free kit (QIAGEN, USA),
according to the manufacturer’s instructions. The puri-
fied plasmid was digested by ApaL I at position 4361,
resulting in linear molecules with similar staggered
(“sticky”) ends, and the gel extract purified by using the
QIAEX II Extraction Kit. DNA concentration was deter-
mined by using a NanoDrop™ 1000 spectrophotometer
(Thermo Fisher Scientific Inc., Waltham, MA, USA).
Linearized DNA was diluted to 100 ng/μL in MilliQ®
water, aliquoted and stored at −20 °C until use.In vitro maturation (IVM) and fertilization (IVF) of
embryos
Water buffalo ovaries (Bubalus bubalis) were collected
from a local abattoir within 20–30 min after slaughter
and transported to the laboratory in a thermos con-
taining phosphate-buffered saline (PBS) at 30–35 °C
within 4–6 h. Buffalo cumulus-oocyte complexes
(COCs) were recovered by aspiration of buffalo folli-
cles (diameter 2–6 mm) using a 10 mL disposable
syringe with 18-gauge needle. Only oocytes with com-
pact, non-atretic cumulus oophorus-corona radiata,
and a homogenous ooplasm were selected for IVM.
The IVM medium comprised TCM-199, supplemented
with 26.2 mmol/L NaHCO3, 5 mmol/L HEPES, 5 % es-
trous cow serum (OCS, self-preparation), 2 % bovine fol-
licular fluid (BFF) and 0.1 ng/μL FSH). COCs were
transferred to a 35 mm glass dish containing 1.5 mL
IVM medium and cultured for 20–22 h under a hu-
midified atmosphere of 5 % CO2 in air at 38.5 °C.
After IVM, buffalo COCs were fertilized with proven
water buffalo sperm using our standard IVF proced-
ure [23].Cytoplasmic injection
Presumptive buffalo zygotes which had extruded the sec-
ond polar body were selected and transferred to a 50 μL
drop of culture medium in a 60 mm dish overlaid by
mineral oil. pEGFP-N1 plasmid was loaded into a micro-
injection needle (inner tip diameter 4–5 μm). Using
manual micromanipulators (NT88-V3, Narishige, Japan)
and micro-injectors (CellTram® Oil, Eppendorf, Germany)
mounted to an inverted microscope (Nikon T300, Japan),
approximately 12 pl plasmid was injected into the zygote
cytoplasm. The estimated injected volume (V) was
calculated from the average inner radius of the injection
needle (r = 4.5 μm) and length of the injected liquid
column (h = 200 μm) by using the formula V = πr2 * h.
The basic micromanipulation medium was TCM-199,
supplemented with 5 mmol/L NaHCO3, 5 mmol/L
HEPES and 5 % OCS. After injection, the zygotes were
washed twice in TCM-199, supplemented with 3 % OCS
culture medium and transferred into culture drops.In vitro culture (IVC)
Following cytoplasmic injection, 10–15 zygotes were
transferred to a 30 μL drop of culture medium and co-
cultured with primary cumulus cells. All cultures were
overlaid with mineral oil and done in an incubator with
5 % CO2 in humidified air at 38.5 °C. The culture
medium was replaced every 48 h. Cleavage was evalu-
ated 48 h after IVC, and the number of morulae and
blastocysts determined on D7.
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EGFP expression was observed under an epifluorescence
inverted microscope (NikonT300, Japan) on D7. Briefly,
different stages of implantation embryos were exposed
to blue light (excitation wavelength 488 nm, emission
wavelength 530 nm), the EGFP expression signal was
observed and fluorescent photos acquired with a CCD
camera (DS-5Mc, Nikon, Japan).
Determination of embryo cell numbers
Embryos were stained with 1 mg/mL Hoechst 33342
(B2261) for 10 min, washed twice in PBS and single
blastocysts mounted into a drop of acid solution (50 mL
MilliQ® H2O + 100 μL 5 N HCl + 50 μL Tween-20) on
glass slides. Images were acquired as described above
and total nuclei numbers were manually counted.
Embryo transfer and pregnancy monitoring
Embryo development into blastocysts was assessed seven
days after insemination (D7). EGFP-positive blastocysts
were identified using an inverted fluorescence micro-
scope as described above. EGFP-positive blastocysts
were scored, and morphological grade 1 and 2 blasto-
cysts (i.e. with a symmetrical and spherical ICM of
uniform size, color and density) were selected for embryo
transfer. Recipient hybrid buffalo, derived from crossing
local swamp buffalo breeds with Murrah river buffalos
and purchased from local farmers, were synchronized as
described [24]. On D7 following estrus (estrus = D0 = day
of IVF), EGFP-positive blastocysts were transferred non-
surgically into the uterine lumen ipsilateral to the corpus
luteum. The pregnancy status of recipient cows was deter-
mined on D40 of gestation by using ultrasonography
(Aloka SSD-500 scanner with a 5 MHz linear rectal probe,
Aloka Co Ltd, Tokyo, Japan).
Transgene detection
Buffalo calves were delivered after gestation. To detect the
integration of exogenous genes in these transgenic buffalo
calves, genomic DNA from ear tissue was extracted and
used as template to set up polymerase chain reaction
(PCR). EGFP- specific amplification was performed by
using the following primer pair: Forward: 5'- CTGGTC
GAGCTGGACGGCGAC (724–744 in pEGFP-N1: within
EGFP coding sequence) -3'; Reverse: 5'-CTACAAAT
GTGGTATGGCTGA- (1443–1423 in pEGFP-N1: be-
tween EGFP coding sequence and SV40 poly A) 3′; PCR
conditions were: pre-denature 95 °C for 5 min, and then
95 °C for 45 s, 60 °C for 45 s, 72 °C for 45 s for 35 cycles,
and a last extension at 72 °C for 7 min; the PCR product
size was 720 bp.
Integration of the EGFP gene was also determined by
Southern blot. Briefly, 20 μg of genomic DNA from ear
tissue was digested with BamH I, separated on a 1 %agarose gel and blotted onto a nylon membrane. An
EGFP probe fragment was amplified by using the same
primers as for PCR. Genomic DNA extracted from non-
transgenic buffalo ear tissue was used as a negative con-
trol. Random-primed DIG-11-dUTP labeling of the
DNA probe was carried out using the ‘High Prime DNA
Labeling and Detection Starter Kit II’ (Roche, USA),
according to the manufacturer’s instructions.
Detection of EGFP expression
Buffalo ear tissue was harvested by removing the hairs
with a scalpel blade, rinsing thoroughly in cold PBS, and
fixing the cells in 4 % fresh paraformaldehyde at 4 °C
overnight. The tissues were washed and perfused in
gradient concentration of sucrose solution (5 %, 10 %,
15 %, 30 %) at 4 °C, before embedding in CRYO-OCT
Tissue-Tek™ (Fisher Scientific, USA). Cryo-sections
were cut at 15 μm thickness and observed under a
confocal laser scanning microscope (Zeiss LSM
510META, Germany) to identify EGFP expression.
Images were acquired with an AxioCam (Zeiss), keeping
all microscope and laser settings kept constant
between different groups and replicates. Brightfield
and fluorescent images were digitally enhanced for
brightness and contrast in Corel Paint Shop Pro XI
(‘Histogram adjustment’). The same settings were
used for images of all three groups.
Statistical analysis
Statistical significance was accepted at P < 0.05 and de-
termined using the two-tailed Fisher exact test for inde-
pendence in 2 x 2 tables for developmental data and
transgene expression (Tables 1, 2) or the paired two-
tailed Student t-test for cell counts. All values are pre-
sented as mean ± SD, unless indicated otherwise.
Results and discussion
We focused on two parameters for optimization, namely
i) DNA concentration and ii) injection time point.
Optimizing amount of injected DNA
In principle, higher amounts of exogenous DNA should
favor DNA integration into the genome. Accordingly, we
observed an increase in EGFP-positive blastocysts with
increasing DNA concentrations. For the dose–response
test, 5, 20 and 50 ng/μL exogenous linear DNA (corre-
sponding to ~1x104, ~4x104 and ~1x105 copies, respect-
ively) were introduced into buffalo zygotes 7–8 h after
IVF. For a similar size plasmid, this represents ~100-fold
more injected DNA molecules than in a comparable
mouse study [14]. Following seven days of IVC, embryo
development and EGFP expression were determined
(Table 1, Fig. 1a). The rate of EGFP-positive blastocysts
was significantly higher in both 20 ng/μL and 50 ng/μL





Blastocyst development EGFP+ Blastocysts Net yield EGFP+
(% ± SD)a (% ± SD)b Blastocysts (% ± SD)c
0 ng/μL 3 57 49 (86.0 ± 4.9) 18 (31.6 ± 4.1)d 0 0
5 ng/μL 3 110 83 (75.5 ± 2.1) 28 (25.5 ± 1.7)de 8 (28.6 ± 5.6)d 7.3 ± 1.6
20 ng/μL 3 98 72 (73.5 ± 1.8) 22 (22.4 ± 6.8)de 15 (68.2 ± 5.8)e 15.3 ± 3.7
50 ng/μL 3 106 76 (71.7 ± 5.6) 15 (14.2 ± 3.8)e 12 (80.0 ± 18.0)e 11.3 ± 3.8
n number of independent experiments;a proportion of embryos placed into IVC (N) that developed into D7 blastocysts (B) grade 1–3;b proportion of EGFP+ blastocysts out
of total D7 blastocysts;c proportion of EGFP+ blastocysts out of N;d, e rows with different superscripts within a column differ P< 0.05 from non-injected control (‘0 ng/μL’)
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28.6 ± 5.6 %, P < 0.05). These findings are comparable to
the 44–71 % fluorescent blastocysts previously achieved
by injecting 10 ng/μL plasmid into bovine zygotes [25].
However, embryo development was compromised at
50 ng/μL compared to non-injected IVF controls (14.2 ±
3.8 % vs. 31.6 ± 4.1 %, P < 0.05). A similar inverse rela-
tionship between efficiency of transgenesis and embryo
development was previously observed in mouse pro-
nuclear [26] and cytoplasmic injection [12]. We there-
fore used 20 ng/μL DNA for optimizing the injection
time point in the next set of experiments.
Optimizing time point of injection
For efficient transgene integration, the embryonic gen-
ome has to be accessible to the exogenous DNA. There-
fore, the timing of DNA injection with respect to the
period of pronuclear formation and chromatin remodel-
ing is critical. We next compared different time points
of injection with respect to embryo development and
frequency of transgene expression (Table 2). Buffalo
zygotes were cytoplasmically injected at 7–8 hpi, 12–13
hpi and 18–19 hpi. In analogy to bovine, these time
points should roughly correspond to early (pronuclei
stages PN1-3), medium (PN3-6) and late (PN5-6) pro-
nuclei formation, respectively [27]. Non-injected IVF
zygotes served as control. There were no significant
differences in cleavage rates between these time points.
Blastocyst development tended to be better at earlier time
points but these differences were not significant. Accord-
ingly, the proportion of EGFP-positive blastocysts was sig-







No injection 3 71 59 (83.1 ± 2.6) 25
7–8 hpi 3 116 100 (86.2 ± 3.6) 30
12–13 hpi 3 102 83 (81.4 ± 3.8) 23
18–19 hpi 3 78 62 (79.5 ± 5.5) 16
n number of independent experiments;a proportion of embryos placed into IVC (N)
blastocysts out of total D7 blastocysts;c proportion of EGFP+ blastocysts out of N;d,
non-injected control37.5 ± 2.9 %, P < 0.05) and their net yield was more than
doubled between these two time points (16.4 ± 5.9 % vs
7.7 ± 2.9 %, P = 0.12). A similar increase in EGFP-positive
blastocysts was previously observed when DNA-liposome
complexes were injected into bovine oocytes vs zygotes at
16 hpi, resulting in net efficiencies of 0 % vs 12 %, respect-
ively [22]. Our finding is consistent with the chronology of
early subcellular events following fertilization. At the earli-
est injection time point, both maternal and paternal
genomes are not yet fully enclosed by their respective pro-
nuclear membranes and therefore accessible. The male
genome is also undergoing chromatin de-condensation,
protamine removal and histone exchange [27–29]. Col-
lectively, these events should facilitate transgene insertion.
At the latest time point, when pronuclear membranes
have fully formed and the pronuclei have reached their
maximal size, access to the genome will be more restricted
and the chances of integration reduced. Post-replicative
transgene insertion into S-phase chromatin at this stage
will result in mosaicism if only one of the two daughter
cells inherits the transgenic chromosomes, whereas trans-
gene insertion prior to DNA replication will decrease the
likelihood of mosaicism. Taken together, we settled on
injecting 20 ng/μL DNA at 7–8 hpi as optimized condi-
tions for subsequent experiments.
Cell counts of transgene-expressing blastocysts
We next characterized the morphological quality of
blastocysts derived from our optimized injection con-
ditions. There was no significant difference between
randomly selected EGFP-positive and non-injected
IVF blastocysts with respect to total cell counts (70 ±sgene expression
yst development EGFP+ Blastocysts Net yield EGFP+
)a (% ± SD)b Blastocysts (% ± SD)c
(35.2 ± 5.5) 0 0
(25.9 ± 3.9) 19 (63.3 ± 5.9)d 16.4 ± 5.9
(22.5 ± 1.4) 12 (52.2 ± 2.9)d, e 11.8 ± 2.9
(20.5 ± 9.1) 6 (37.5 ± 2.9)e 7.7 ± 2.9
that developed into D7 blastocysts (B) grade 1–3;b proportion of EGFP+
e rows with different superscripts within a column differ P < 0.05 from
Fig. 1 Characterization of EGFP-positive buffalo blastocysts. a. Microscopic evaluation by brightfield (a) and wide-field epifluorescence (a’); scale
bar =100 μm. b. Nuclei numbers in EGFP-positive and non-injected IVF blastocysts. c. Mixed-sex twin buffalo calves born in December 2010
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transgene-expressing blastocysts were not compro-
mised in terms of overall morphological quality.Embryo transfer and detection of transgenic buffalo
calves
To determine their in vivo viability and capacity for full
term development, six EGFP-positive blastocysts were
transferred into the uterine horns of four cross-bred buf-
falo recipients (Table 3). One recipient was pregnant at
D40 and two buffalo calves, one male and one female,
were born on 2 December 2010 (Table 3, Fig. 1c). Since
the GFP expression in embryos could reflect transient
transcription of non-integrated DNA, both animals were
analyzed for EGFP gene integration (Fig. 2a). Genomic
DNA, extracted from ear biopsies of the two calves and
a wild-type control calf, was used as a template. Both
PCR and Southern blot specifically detected presence of
the EGFP transgene in the two buffalo calves that devel-
oped from EGFP-positive blastocysts (Fig. 2b, c). For
single-copy integration, the minimal size of the resulting
BamH I fragment recognized by the Southern probeTable 3 Embryo transfer summary
Recipient nET Pregnancies at D40 Calves born
1 1 0 0
2 2 2 2
3 1 1 0
4 2 0 0
nET number of embryo transferswould be 3.7 kb. For multi-copy integrations (head-to-
head, head-to-tail or mixed), the next bigger fragment
size would be 3.7 + 1.0 = 4.7 kb. Multi-copy insertion
would also result in increased signal intensity. The ob-
served fragment sizes and signal intensities are consistent
with head-to-head multi-copy and single-copy integration
in the male and female calf, respectively (Fig. 2c).
We further used confocal laser scanning microscopy
to directly observe EGFP expression in transgenic buf-
falo ear tissue cultures. EGFP signal was specifically ob-
served in all cells from presumptive transgenic primary
tissue cultures, indicating that the randomly integrated
transgene was expressed and functional (Fig. 2d).
The male and female transgenic calves were born after
twin embryo transfer. In cattle, the majority of females
from mixed-sex dizygotic twin pregnancies are freemar-
tins [30]. This condition is due to exchange of cellular
material and hormones between the vasculary connected
twin placentas. As a result, over 90 % of female twins
have abnormally masculinized reproductive organs and
are infertile. This phenomenon also occurs in buffalo
[31]. In our case, the female transgenic calf was diag-
nosed as freemartin by ultrasound analysis, precluding it
from subsequent mating. The male calf has so far not
been mated and analyzed for transgene segregation in
the offspring.Conclusions
We demonstrate that injecting 20 ng/μL exogenous
DNA into buffalo zygotes at 7–8 hpi reproducibly results
in >15 % transgene-expressing blastocysts. This net effi-
ciency compares favorably to studies in mice and other
Fig. 2 Characterization of transgenic buffalo calves derived from cytoplasmic zygote injection. a. Main features of injected pEGFP-N1 plasmid,
showing restriction positions (in brackets), PCR primer binding sites (single arrows), Southern probe location (double block arrow) and expected
amplicon sizes. p = promoter, pA = polyA site, R = resistance; b, c. Detection of EGFP by PCR (b) and Southern blot (c) in genomic DNA extracted
from biopsied ear tissues of transgenic buffalo calves (male, female) and wild-type buffalo ear tissue (WT). Water provided a no template control.
d. Ear tissue sections from transgenic calves (male, female) and wild-type control calf (WT) observed by confocal laser scanning microscopy
(Brightfield, EGFP and merged images, respectively)
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differences that affect stability and processing of exogen-
ous DNA [32]. Using these optimized parameters, we
produced the first transgenic buffalos from cytoplasmic
injection. This technique would also be applicable to
non-reporter transgenes, which could be detected on
biopsies prior to embryo transfer [33, 34].
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